Navigation Links
Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
Date:8/4/2010

CAMBRIDGE, Mass., Aug. 4 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the appointment of Antonin (Tony) de Fougerolles, Ph.D., as Chief Scientific Officer. Dr. de Fougerolles’ appointment as Tolerx’s CSO will provide leadership for the company’s research and early-stage product development programs involving novel therapies based on T cell modulation.  Dr. de Fougerolles brings to Tolerx more than 15 years of biotech R&D experience and expertise in immunology. He will direct the company’s R&D activities and strengthen Tolerx’s leadership in T cell immunology.

(Photo: http://photos.prnewswire.com/prnh/20100804/NE45601 )

(Photo: http://www.newscom.com/cgi-bin/prnh/20100804/NE45601 )

"We are delighted and enthusiastic about Tony joining us as CSO at this pivotal time, when Tolerx is poised to make substantial progress in expanding our pipeline of drug candidates based on T cell modulation,"
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes
2. Tolerx Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes
3. Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting
4. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
5. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
6. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
7. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
8. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
9. InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
10. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
11. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... CAMBRIDGE, Mass. , Oct. 22, 2014 ... Cambridge, MA is revolutionizing spinal cord ... technique has been shown to outperform in tissue regrowth ... with the scaffold.  Made from an FDA approved polymer, ... dioxide; making it harmless to the human body. NVIV ...
(Date:10/22/2014)... and AUSTIN, Texas , Oct. ... LLC today announced they have entered into a ... immunotherapies designed to target cancers. PhosImmune ... displayed on the surfaces of tumor cells in ... (PTTs), derived from proteins that play a role ...
(Date:10/22/2014)... Oct. 22, 2014  Recently published clinical studies of ... already substantial database of evidence. This data has led ... Stretta therapy for sufferers of refractory GERD. ... supporting Stretta therapy as a safe and effective ... Stretta therapy available to nearly 50 million Americans. The ...
Breaking Medicine Technology:InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2
... Reportlinker.com announces that a new market research report ... Global Vertebral Compression Fracture Devices Industry ... analyzes the Global market for Vertebral Compression Fracture ... are provided for the period 2006 through 2015. ...
... that a new market research report is available in ... http://www.reportlinker.com/p0155051/Antidiabetics-market-forecast.html ... billion in 2019 for the seven major markets. Januvia ... expiry of Actos, with franchise sales reaching nearly $6 ...
Cached Medicine Technology:Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 2Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 3Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 4Reportlinker Adds Global Vertebral Compression Fracture Devices Industry 5Reportlinker Adds Antidiabetics Market Forecast 2
(Date:10/22/2014)... Pass, OR (PRWEB) October 22, 2014 ... Southern California’s fresh water supply runs dangerously low, Southern ... change. Southern Oregon’s rivers, despite the lowest mountain snow ... even in late summer and early autumn.* That was ... authors of the new book “Hiking Southern Oregon,” during ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Although there are only ... time for many people who have trouble finding time within their ... to exercise for long periods of time to get in shape. ... goals while on the go. , Change Up Your Commute ... to work to add some exercise into your daily routine. If ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... may be showing a genetic propensity for obesity as toddlers, ... been linked to increased body fat, but the same genes ... the researchers said. At 1 year, kids with these ... 3, however, these genes were linked to excessive weight gain, ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 ... fertilization (IVF) -- the incubation of embryos in a laboratory ... the vagina, new research suggests. Scientists from the United ... might sharply cut costs for pricey IVF procedures among certain ... those who don,t live near big-city assisted reproduction centers, the ...
(Date:10/20/2014)... October 20, 2014 The newly updated ... source of thousands of facts, figures and forecasts on ... 68 medical sector forecast categories the Worldwide Medical ... regional and national views on the worldwide medical market ... The report gives you data for 2010-2019, covering each ...
Breaking Medicine News(10 mins):Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4
... third of women surveyed about their beliefs surrounding miscarriage and ... mood could negatively affect her baby. , One in ... upsetting situations could hurt her unborn child, and one in ... , Despite those beliefs, relatively few of the women ...
... The preterm birth rate rose again in 2005 and preliminary ... need for a sustained, comprehensive plan to address this growing ... consequences of an early birth, the more determined the March ... how it can be prevented, said Dr. Jennifer L. Howse, ...
... A new study recently published in the Journal of Cosmetic ... slenderizing thighs. , The Brazilian researchers studied 99 women treated ... solution. The women used the cream twice daily for 30 ... at the end of the study, the slimming effect was ...
... FORT WORTH, Texas, Dec. 6 A Tarrant County ... 75-year-old Fort Worth man who,died after his physician failed ... six hours over two days before issuing their,verdict on ... W. Lowe III.,The jury found that Dr. Paul J. ...
... Dispensed $24 Million Worth of,Prescription Drugs Through Rogue ... Luxury Lifestyle, Including Seven,Convertibles, Four Stretch Limousines & ... The National Health,Care Anti-Fraud Association (NHCAA) today is ... Services, and Treasury the 2007,Fraud "Investigation of the ...
... to Fix Flaws in Medicaid Generic Prescription,Drug System, ... pharmacy owners held a press conference at Capital ... Mitch McConnell,(R-Ky.) to help ensure S.1951, the Fair ... the Senate floor for a vote before they ...
Cached Medicine News:Health News:Miscarriage myths persist despite prevalence of medical information 2Health News:Miscarriage myths persist despite prevalence of medical information 3Health News:Miscarriage myths persist despite prevalence of medical information 4Health News:Jury Awards $5.25 Million Malpractice Verdict Against Fort Worth Doctor 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 3Health News:Kentucky Pharmacists Urge Senator McConnell to Put Patients First 2Health News:Kentucky Pharmacists Urge Senator McConnell to Put Patients First 3
Extremely fine straight....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
Micro 2000 suture forceps light-weight instruments with blue-colored anodized round handles, extremely light weight, well balanced, easy to handle, fatigueless working, easy to maintain, corrosion-re...
Round tip, sharp all around, angled....
Medicine Products: